Product Information
AMLODIPINE-OLMESARTAN 5-40 MG is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3122 per EA under NDC 65862085530. Its NADAC has been published 479 times since Jun 21, 2017.
FDA first approved this application on May 15, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 40 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862085530
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA206906FDA Approved
5/15/2017
TE Code
AB
On Market Since
5/15/2017
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has been published 479 times since Jun 21, 2017, and over the history we have for it it has declined 70.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3122 per EA |
|---|---|
| All-time high | $1.0470 (Jul 12, 2017) |
| All-time low | $0.2762 (Apr 22, 2026) |
| 52-week high | $0.3755 |
| 52-week low | $0.2762 |
| Median price | $0.4484 |
| Average price | $0.5398 |
| Largest weekly change | -45.3% (Nov 18, 2020) |
| Weeks tracked | 479 |
| Tracking since | Jun 21, 2017 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-OLMESARTAN 5-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-40 MG, manufactured by Aurobindo Pharma Limited, is $0.3122 per EA (NDC 65862085530), effective Aug 19, 2026.
How has the price of AMLODIPINE-OLMESARTAN 5-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has declined 70.2%. It has been tracked across 479 weekly CMS publications since Jun 21, 2017.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-40 MG?
Since Jun 21, 2017, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has ranged from a low of $0.2762 (Apr 22, 2026) to a high of $1.0470 (Jul 12, 2017), with a median of $0.4484 per EA.
Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-40 MG?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMLODIPINE-OLMESARTAN 5-40 MG, is $0.2788 per EA — about 11% below AMLODIPINE-OLMESARTAN 5-40 MG.
Who manufactures AMLODIPINE-OLMESARTAN 5-40 MG?
AMLODIPINE-OLMESARTAN 5-40 MG (NDC 65862085530) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.